4.54
price up icon4.85%   0.21
 
loading

Neuronetics Inc Aktie (STIM) Neueste Nachrichten

pulisher
Mar 09, 2025

Earnings call transcript: Neuronetics Q4 2024 sees revenue growth, stock rises - Investing.com Australia

Mar 09, 2025
pulisher
Mar 08, 2025

Neuronetics, Inc. to Host Earnings Call - ACCESS Newswire

Mar 08, 2025
pulisher
Mar 08, 2025

Neuronetics Reports 2024 Financial Results and Strategic Advances - MSN

Mar 08, 2025
pulisher
Mar 08, 2025

William Blair Increases Earnings Estimates for Neuronetics - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Neuronetics Inc (STIM) Reports 8% Revenue Growth in Q3 2023 - GuruFocus.com

Mar 07, 2025
pulisher
Mar 07, 2025

Neuronetics CFO Stephen Furlong sells $8,364 in stock - Investing.com India

Mar 07, 2025
pulisher
Mar 07, 2025

Neuronetics (NASDAQ:STIM) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

(STIM) Technical Data - Stock Traders Daily

Mar 06, 2025
pulisher
Mar 06, 2025

Neuronetics executive sells shares worth $1,688 By Investing.com - Investing.com Canada

Mar 06, 2025
pulisher
Mar 06, 2025

Neuronetics executive sells shares worth $1,688 - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Neuronetics, Inc.'s (NASDAQ:STIM) Shares Leap 69% Yet They're Still Not Telling The Full Story - Simply Wall St

Mar 06, 2025
pulisher
Mar 06, 2025

Transcranial Magnetic Stimulator Market Growth and Future - openPR

Mar 06, 2025
pulisher
Mar 05, 2025

Neuronetics’ Earnings Call: Growth Amid Challenges - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Neuronetics Grants Inducement Awards to New Employees - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

Neuronetics, Inc. (NASDAQ:STIM) Q4 2024 Earnings Call Transcript - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

Neuronetics stock holds Market Outperform amid merger growth By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

Neuronetics Inc (STIM) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Rising Expenses ... By GuruFocus - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

Neuronetics Inc (STIM) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Rising Expenses ... - Yahoo Finance

Mar 05, 2025
pulisher
Mar 05, 2025

Neuronetics’ Strategic Merger with Greenbrook TMS Fuels Growth and Positive Outlook - TipRanks

Mar 05, 2025
pulisher
Mar 04, 2025

Neuronetics Reports Growth Amid Strategic Acquisitions - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Canaccord raises Neuronetics stock target to $8, maintains buy rating By Investing.com - Investing.com Australia

Mar 04, 2025
pulisher
Mar 04, 2025

Canaccord raises Neuronetics stock target to $8, maintains buy rating - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Neuronetics stock soars to 52-week high, hits $5.08 By Investing.com - Investing.com Canada

Mar 04, 2025
pulisher
Mar 04, 2025

Neuronetics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Neuronetics, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2025 - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Neuronetics stock soars to 52-week high, hits $5.08 - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Neuronetics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

Neuronetics: Q4 Earnings Snapshot - mySA

Mar 04, 2025
pulisher
Mar 04, 2025

Neuronetics rises on upbeat 2025 revenue forecast - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

Neuronetics, Inc. Q4 Loss Increases, Misses Estimates - Nasdaq

Mar 04, 2025
pulisher
Mar 04, 2025

NEURONETICS Earnings Results: $STIM Reports Quarterly Earnings - Nasdaq

Mar 04, 2025
pulisher
Mar 04, 2025

Neuronetics: Q4 Earnings Snapshot -March 04, 2025 at 07:37 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Neuronetics shares surge over 5% post Q4 revenue beat By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Neuronetics Reports Q4 2024 Results and Strategic Moves - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Neuronetics shares surge over 5% post Q4 revenue beat - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results - The Manila Times

Mar 04, 2025
pulisher
Mar 04, 2025

Can Neuronetics' $22M Cost Synergies Turn Its Widening Losses Around? Q4 Earnings Deep Dive - StockTitan

Mar 04, 2025
pulisher
Mar 04, 2025

Neuronetics reports inducement grants - Medical Buyer

Mar 04, 2025
pulisher
Mar 04, 2025

Neuronetics Approves Cash Incentives for Key Executives - TipRanks

Mar 04, 2025
pulisher
Mar 03, 2025

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

Neuronetics Awards 24,750 Shares in RSUs to New StaffWhat This Means for STIM - StockTitan

Mar 03, 2025
pulisher
Mar 03, 2025

Neuronetics Inc (STIM) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance

Mar 03, 2025
pulisher
Mar 02, 2025

Neuronetics (STIM) to Release Earnings on Tuesday - Defense World

Mar 02, 2025
pulisher
Feb 28, 2025

Neuronetics Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView

Feb 28, 2025
pulisher
Feb 27, 2025

Transcranial Magnetic Stimulator Market is Thriving Worldwide| Magstim, BrainsWay, Nexstim Plc, Neuronetics - openPR

Feb 27, 2025
pulisher
Feb 23, 2025

Have Neuronetics Insiders Been Selling Stock? - Simply Wall St

Feb 23, 2025
pulisher
Feb 22, 2025

Neuronetics, Inc. (STIM): Among the Hot Penny Stocks to Buy Now - Insider Monkey

Feb 22, 2025
pulisher
Feb 22, 2025

Neuronetics to Announce Q4 2024 Results on March 4, 2025 - MyChesCo

Feb 22, 2025
pulisher
Feb 21, 2025

Neuronetics CEO Keith Sullivan sells shares for $229,236 By Investing.com - Investing.com South Africa

Feb 21, 2025
$140.02
price up icon 5.57%
diagnostics_research DGX
$168.15
price down icon 2.87%
diagnostics_research LH
$239.25
price down icon 2.00%
diagnostics_research WAT
$378.85
price down icon 2.93%
diagnostics_research MTD
$1,243.17
price down icon 3.96%
diagnostics_research IQV
$183.48
price down icon 2.81%
Kapitalisierung:     |  Volumen (24h):